Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
OR2B2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LOC285181 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors
S100PBP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACSL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNRNP70 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IRF4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
CAPZA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CSRNP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLDND1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL1RL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DDX3X - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PKLR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CACNA1G - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
INTS4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SDHAF3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANGPT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on